12-8058955-T-TC
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_004054.4(C3AR1):c.1230_1231insG(p.Lys411GlufsTer18) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Consequence
C3AR1
NM_004054.4 frameshift
NM_004054.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.907
Genes affected
C3AR1 (HGNC:1319): (complement C3a receptor 1) C3a is an anaphylatoxin released during activation of the complement system. The protein encoded by this gene is an orphan G protein-coupled receptor for C3a. Binding of C3a by the encoded receptor activates chemotaxis, granule enzyme release, superoxide anion production, and bacterial opsonization. [provided by RefSeq, May 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C3AR1 | NM_004054.4 | c.1230_1231insG | p.Lys411GlufsTer18 | frameshift_variant | 2/2 | ENST00000307637.5 | NP_004045.1 | |
C3AR1 | NM_001326475.2 | c.1230_1231insG | p.Lys411GlufsTer18 | frameshift_variant | 2/2 | NP_001313404.1 | ||
C3AR1 | NM_001326477.2 | c.1230_1231insG | p.Lys411GlufsTer18 | frameshift_variant | 2/2 | NP_001313406.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C3AR1 | ENST00000307637.5 | c.1230_1231insG | p.Lys411GlufsTer18 | frameshift_variant | 2/2 | 1 | NM_004054.4 | ENSP00000302079 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 33
GnomAD4 exome
Cov.:
33
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
C3AR1-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 02, 2022 | The C3AR1 c.1230dupG variant is predicted to result in a frameshift and premature protein termination (p.Lys411Glufs*18). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Furthermore, it is located in the terminal exon of this gene. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.